Genmab to Submit Biologics License Application to U.S. Food

Company Announcement COPENHAGEN, Denmark; June 30, 2022 – Genmab A/S (Nasdaq: GMAB) today announced its intent to submit a biologics license application...

Related Keywords

Copenhagen ,Køavn ,Denmark ,Japan ,Tokyo ,New Jersey ,United States ,Netherlands ,Austria ,Vienna ,Wien ,Kalvebod Brygge ,Marisol Peron ,Andrew Carlsen ,Macrophage Propertiesj Immunol ,Twitter ,Drug Administration ,Exchange Commission ,Hodgkin Lymphoma Research Foundation ,Meeting Of The European Hematology Association ,Development Of Novel Anti ,Corporate Affairs ,Diffuse Large Lymphoma Research Foundation ,Company Announcement ,Presidential Symposium ,Annual Meeting ,European Hematology Association ,Chief Executive Officer ,Largeb Cell Lymphoma ,Media Contact ,Senior Vice President ,Investor Relations ,Vice President ,Media Release ,Annual Report ,Y Shaped Genmab ,Research Foundation ,Hodgkin Lymphoma ,Rev Oncol ,Clinically Utilized ,Directed Antibodies ,Macrophage Properties ,Novel Anti Cd ,Cell Surface ,Cancer Sci ,Copenhagen Stock Exchange Gen ,Genmaba S ,Bispecific Antibody ,Lymphoma ,Biologics License Application ,